Intelligent Drug Discovery Market Valuation Worth USD 3,711.8 Million in 2027 | Emergen Research

Increasing prevalence various chronic diseases, rising adoption of cloud-based applications, and high focus on reducing costs of drug discovery and development are expected to drive global Intelligent Drug Discovery market growth.

According to Emergen Research, the global intelligent drug discovery market size was USD 258.9 million in 2019 and is expected to reach USD 3,711.8 million in 2027 and register a robust revenue CAGR of 39.4% during the forecast period, 2020-2027.

Market Dynamics:

Over the recent years, Artificial Intelligence (AI) and Machine Learning (ML) technology is rapidly gaining traction in the healthcare and pharmaceutical sectors for drug discovery and development. Many pharmaceutical companies are inclining toward AI solutions such as deep learning and machine learning for improving overall efficiency.  Intelligent drug discovery helps in improving identification of drug targets and precision in manufacturing and reducing product quality and time. Factors such as increasing need reducing overall time taken during the drug discovery processes, increasing focus on developing chronic disease treatment, and rising investments in R&D activities are expected to drive global Intelligent Drug Discovery market revenue growth. 

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

However, lack of data sets in drug discovery processes, low awareness about intelligent drug discovery in many countries around the globe, and dearth of skilled labor are some key factors that can hamper overall Intelligent Drug Discovery market growth to a certain extent during the forecast period.

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Cardiovascular Diseases Segment to Register Robust Revenue CAGR:

The cardiovascular diseases segment is expected to register robust revenue CAGR over the forecast period. This can be attributed to increasing prevalence of cardiovascular diseases such as coronary heart disease, aortic disease, stroke, and arrhythmia, ongoing research on cardiovascular disease treatment, and high demand for personalized medicine. 

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

Pharmaceutical & Biotechnology Companies Segment To Account for Largest Revenue Share:

The pharmaceutical and biotechnology companies segment is expected to account for largest revenue share during the forecast period owing to large patient base, increasing investments in research-based activities, growing demand for cost-effective drugs, and rapid adoption of advanced technologies. 

North America to Lead In Terms of Revenue Share:

North America is expected to account for largest revenue share in the global market during the forecast period attributable to increasing prevalence of various diseases, rapid adoption of Artificial Intelligence (AI) in drug discovery, and presence of leading companies. Other factors such as increasing number of pharmaceutical companies across the region, high focus on offering the best healthcare services, increasing funds for drug development, and rising investments in research and development activities are expected to fuel North America market growth during the forecast period. 

Major Companies in the Market Include:

  • IBM Corporation
  • Microsoft Corporation
  • Google
  • NVIDIA Corporation
  • Cloud Pharmaceuticals, Inc.
  • Atomwise, Inc.
  • Insilico Medicine
  • Exscientia
  • Bioage
  • Envisagenics

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

For the purpose of this report, Emergen Research has segmented into the global intelligent drug discovery market on the offering, technology, application, end-user, and region:

Offering Outlook (Revenue, USD Million; 2017-2027)

  • Software
  • Services

Technology Outlook (Revenue, USD Million; 2017-2027)

  • Machine Learning
    • Supervised Learning
    • Deep Learning
    • Reinforcement Learning
    • Unsupervised Learning
  • Other Technologies

Application Outlook (Revenue, USD Million; 2017-2027)

  • Neurodegenerative Diseases
  • Metabolic Diseases
  • Immuno-Oncology
  • Cardiovascular Diseases
  • Others

End-User Outlook (Revenue, USD Million; 2017-2027)

  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Research Centers and Academic & Government Institutes

Regional Outlook (Revenue, USD Million; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Looking to Purchase Reports in Bundle [Schedule a Call with An Analyst]@

Read Latest Reports Published by Emergen Research:

Next Generation Visualization and Navigation Systems Market, By Product (Robotics Surgical Navigation Systems, Robotics Visualization Systems), By Applications (Diagnostics Procedures, Surgical Procedures), By End-Use, and By Region Forecast to 2030.

Radiation Therapy in Oncology Market, By Type (Internal Beam Radiation Therapy, External Beam Radiation Therapy), By Technology (Image Guided Radiotherapy), By Application (Breast Cancer, Lung Cancer), and By Region Forecast to 2030.

Eco Friendly Bitumen Market Size, Share, Trends, By Source (Bio-Based, Recycled, Natural), By Grade (Paving Grade, Oxidized, Hard Grade, Others), By Application (Construction, Waterproofing, Paints and Coatings, Others), and By Region, Forecast to 2030.

Weather Alert and Warning Systems Market, By Type (Outdoor Warning Sirens, Local Television and Radio Stations, Cable Television Systems, Cellphone Applications, NOAA Weather Radio, Others), By End-Use, and By Region Forecast to 2030.

Web 3.0 Market Size, Share, Trends, By Type, Blockchain Type (Public, Private, Hybrid, and Others), By Organization Size (Small and Medium-Sized Enterprises, Large Enterprises), By Application, By Vertical, and By Region Forecast to 2030.

Aircraft Seals Market, By Product Type (Static Seals, Dynamic Seals), By Materials, By Aircraft Type, By Application (Aircraft Frame, Engine, Landing Gear System, Avionics & Electrical System), By End-Use, and By Region Forecast to 2030.

Cognitive Electronic Warfare System Market Size, Share, Trends, By Capability (Electronic Attack, Electronic Protection, Electronic Support, and Others), By Platform (Naval, Land, Airborne, Space), By Product, and By Region Forecast to 2030.

Polyaryletherketone Market, By Product Type (Polyether Ether Ketone, Polyether Ketone), By Filler Type (Unfilled, Carbon Filled), By Application (Oil & Gas, Electrical & Electronics, Automotive, and Aerospace), and By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Press Release Available @






Back to news